0001493152-24-004814.txt : 20240202 0001493152-24-004814.hdr.sgml : 20240202 20240202200012 ACCESSION NUMBER: 0001493152-24-004814 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berman Howard CENTRAL INDEX KEY: 0001952986 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 24593560 MAIL ADDRESS: STREET 1: C/O COYA THERAPEUTICS, INC. STREET 2: 5850 SAN FELIPE ST., SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml X0508 4 2024-01-31 0 0001835022 Coya Therapeutics, Inc. COYA 0001952986 Berman Howard 5850 SAN FELIPE ST., SUITE 500 HOUSTON TX 77057 1 1 0 0 Chief Executive Officer 0 Stock Option (right to buy) 5.90 2024-01-31 4 A 0 189680 0.00 A 2034-01-31 Common Stock, par value $0.0001 per share 189680 189680 D The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date. /s/ David Snyder, Attorney-in-Fact 2024-02-02